Kyverna Therapeutics, Inc. SEC EDGAR Filings (CIK 0001994702)

SEC EDGAR filings, ownership reports, and insider transactions for Kyverna Therapeutics, Inc..

Symbol
KYTX on Nasdaq
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
5980 Horton Street, Suite 550, Emeryville, CA, 94608
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Kyverna Therapeutics, Inc. has filed 133 SEC EDGAR filings since 05 Oct 2023

Latest Filings

Recent SEC filings for Kyverna Therapeutics, Inc. including 4, 8-K, 424B5 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 14 Jan 2026 12 Jan 2026
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Jan 2026 08 Jan 2026 001-41947
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 22 Dec 2025 18 Dec 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 22 Dec 2025 18 Dec 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 18 Dec 2025 17 Dec 2025 001-41947
424B5 Open 424B5 document View SEC filing for 424B5 PROSPECTUS SUPPLEMENT 18 Dec 2025 333-286180
4 Open 4 document View SEC filing for 4 4 17 Dec 2025 15 Dec 2025
FWP Open FWP document View SEC filing for FWP FREE WRITING PROSPECTUS 17 Dec 2025 333-286180
424B5 Open 424B5 document View SEC filing for 424B5 PROSPECTUS SUPPLEMENT 15 Dec 2025 333-286180
144 Open 144 document View SEC filing for 144 15 Dec 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 15 Dec 2025 15 Dec 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 15 Dec 2025 15 Dec 2025 001-41947
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 17 Nov 2025 005-94441
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Nov 2025 30 Sep 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Nov 2025 12 Nov 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 03 Nov 2025 02 Nov 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 29 Oct 2025 29 Oct 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 29 Oct 2025 29 Oct 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 25 Sep 2025 19 Sep 2025 001-41947
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Aug 2025 30 Jun 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Aug 2025 12 Aug 2025 001-41947
4 Open 4 document View SEC filing for 4 4 01 Jul 2025 30 Jun 2025
3 Open 3 document View SEC filing for 3 3 01 Jul 2025 30 Jun 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 30 Jun 2025 30 Jun 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 03 Jun 2025 29 May 2025 001-41947
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
4 Open 4 document View SEC filing for 4 4 02 Jun 2025 29 May 2025
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 May 2025 31 Mar 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 May 2025 13 May 2025 001-41947
EFFECT Open EFFECT document View SEC filing for EFFECT 15 Apr 2025 333-286180
4 Open 4 document View SEC filing for 4 4 15 Apr 2025 11 Apr 2025
4 Open 4 document View SEC filing for 4 4 15 Apr 2025 11 Apr 2025
4 Open 4 document View SEC filing for 4 4 15 Apr 2025 11 Apr 2025
424B5 Open 424B5 document View SEC filing for 424B5 424B5 15 Apr 2025 333-286180
ARS Open ARS document View SEC filing for ARS ARS 14 Apr 2025 31 Dec 2024 001-41947
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 14 Apr 2025 001-41947
DEF 14A Open DEF 14A document | Open XBRL data View SEC filing for DEF 14A DEF 14A 14 Apr 2025 29 May 2025 001-41947
CORRESP Open CORRESP document View SEC filing for CORRESP 11 Apr 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 01 Apr 2025 333-286180
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 27 Mar 2025 27 Mar 2025 001-41947
S-8 Open S-8 document View SEC filing for S-8 S-8 27 Mar 2025 333-286181
S-3 Open S-3 document View SEC filing for S-3 S-3 27 Mar 2025 333-286180
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 27 Mar 2025 31 Dec 2024 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 27 Mar 2025 27 Mar 2025 001-41947
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 4 24 Jan 2025 22 Jan 2025
3 Open 3 document View SEC filing for 3 3 24 Jan 2025 22 Jan 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 21 Jan 2025 21 Jan 2025 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 13 Jan 2025 13 Jan 2025 001-41947
S-8 Open S-8 document View SEC filing for S-8 S-8 26 Nov 2024 333-283489
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 26 Nov 2024 26 Nov 2024 001-41947
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 Nov 2024 30 Sep 2024 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Nov 2024 08 Nov 2024 001-41947
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 12 Nov 2024 005-94441
4 Open 4 document View SEC filing for 4 4 24 Oct 2024 21 Oct 2024
3 Open 3 document View SEC filing for 3 3 24 Oct 2024 21 Oct 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 21 Oct 2024 20 Oct 2024 001-41947
SC 13G Open SC 13G document View SEC filing for SC 13G FILING KYVERNA THERAPEUTICS, INC. 10 Oct 2024 005-94441
4 Open 4 document View SEC filing for 4 4 18 Sep 2024 16 Sep 2024
4 Open 4 document View SEC filing for 4 4 18 Sep 2024 16 Sep 2024
3 Open 3 document View SEC filing for 3 3 18 Sep 2024 16 Sep 2024
3 Open 3 document View SEC filing for 3 3 18 Sep 2024 16 Sep 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 16 Sep 2024 13 Sep 2024 001-41947
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Aug 2024 30 Jun 2024 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Aug 2024 12 Aug 2024 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 15 Jul 2024 15 Jul 2024 001-41947
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 11 Jul 2024 005-94441
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 Jun 2024 14 Jun 2024 001-41947
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 29 May 2024 28 May 2024
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 May 2024 31 Mar 2024 001-41947
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 May 2024 14 May 2024 001-41947
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 03 May 2024 005-94441
10-K Open 10-K document View SEC filing for 10-K 10-K 26 Mar 2024 31 Dec 2023 001-41947
8-K Open 8-K document View SEC filing for 8-K 8-K 26 Mar 2024 26 Mar 2024 001-41947
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 22 Feb 2024 005-94441
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 20 Feb 2024 005-94441
4 Open 4 document View SEC filing for 4 4 14 Feb 2024 12 Feb 2024
4 Open 4 document View SEC filing for 4 4 14 Feb 2024 12 Feb 2024
4 Open 4 document View SEC filing for 4 4 14 Feb 2024 12 Feb 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2024 12 Feb 2024
4 Open 4 document View SEC filing for 4 4 14 Feb 2024 12 Feb 2024
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 14 Feb 2024 005-94441
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 13 Feb 2024 12 Feb 2024
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 13 Feb 2024
4 Open 4 document View SEC filing for 4 4 12 Feb 2024 12 Feb 2024
8-K Open 8-K document View SEC filing for 8-K 8-K 12 Feb 2024 12 Feb 2024 001-41947
S-8 Open S-8 document View SEC filing for S-8 S-8 08 Feb 2024 333-276952
424B4 Open 424B4 document View SEC filing for 424B4 424B4 08 Feb 2024 333-276523
CERT Open CERT document View SEC filing for CERT 08 Feb 2024 001-41947
3 Open 3 document View SEC filing for 3 3 08 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 08 Feb 2024 07 Feb 2024
EFFECT Open EFFECT document View SEC filing for EFFECT 07 Feb 2024 333-276523
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 3 07 Feb 2024 07 Feb 2024
3 Open 3 document View SEC filing for 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 07 Feb 2024 07 Feb 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 06 Feb 2024 333-276523
CORRESP Open CORRESP document View SEC filing for CORRESP 05 Feb 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 05 Feb 2024
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 05 Feb 2024 001-41947
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 01 Feb 2024 333-276523
CORRESP Open CORRESP document View SEC filing for CORRESP 25 Jan 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 16 Jan 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 16 Jan 2024 333-276523
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 10 Jan 2024 377-06910
DRS/A Open DRS/A document View SEC filing for DRS/A 08 Jan 2024 377-06910
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 05 Jan 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 28 Dec 2023 377-06910
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 15 Dec 2023
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 13 Dec 2023
DRS/A Open DRS/A document View SEC filing for DRS/A 13 Dec 2023 377-06910
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 21 Nov 2023 377-06910
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 09 Nov 2023
DRS/A Open DRS/A document View SEC filing for DRS/A 09 Nov 2023 377-06910
D Open D document View SEC filing for D 07 Nov 2023 021-496597
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 01 Nov 2023 377-06910
DRS Open DRS document View SEC filing for DRS 05 Oct 2023 377-06910

About this filer

Kyverna Therapeutics, Inc. files with the SEC under CIK 0001994702. This page aggregates EDGAR filings and related ownership activity.

Industry: Biological Products, (No Disgnostic Substances).

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages